|
Atomistry » Chlorine » PDB 2yc5-2yj8 » 2yfx | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Chlorine » PDB 2yc5-2yj8 » 2yfx » |
Chlorine in PDB 2yfx: Structure of L1196M Mutant Anaplastic Lymphoma Kinase in Complex with CrizotinibEnzymatic activity of Structure of L1196M Mutant Anaplastic Lymphoma Kinase in Complex with Crizotinib
All present enzymatic activity of Structure of L1196M Mutant Anaplastic Lymphoma Kinase in Complex with Crizotinib:
2.7.10.1; Protein crystallography data
The structure of Structure of L1196M Mutant Anaplastic Lymphoma Kinase in Complex with Crizotinib, PDB code: 2yfx
was solved by
M.Mctigue,
Y.Deng,
W.Liu,
A.Brooun,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 2yfx:
The structure of Structure of L1196M Mutant Anaplastic Lymphoma Kinase in Complex with Crizotinib also contains other interesting chemical elements:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Structure of L1196M Mutant Anaplastic Lymphoma Kinase in Complex with Crizotinib
(pdb code 2yfx). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 2 binding sites of Chlorine where determined in the Structure of L1196M Mutant Anaplastic Lymphoma Kinase in Complex with Crizotinib, PDB code: 2yfx: Jump to Chlorine binding site number: 1; 2; Chlorine binding site 1 out of 2 in 2yfxGo back to Chlorine Binding Sites List in 2yfx
Chlorine binding site 1 out
of 2 in the Structure of L1196M Mutant Anaplastic Lymphoma Kinase in Complex with Crizotinib
Mono view Stereo pair view
Chlorine binding site 2 out of 2 in 2yfxGo back to Chlorine Binding Sites List in 2yfx
Chlorine binding site 2 out
of 2 in the Structure of L1196M Mutant Anaplastic Lymphoma Kinase in Complex with Crizotinib
Mono view Stereo pair view
Reference:
Q.Huang,
T.W.Johnson,
S.Bailey,
A.Brooun,
K.D.Bunker,
B.J.Burke,
M.R.Collins,
A.S.Cook,
J.J.Cui,
K.N.Dack,
J.G.Deal,
Y.Deng,
D.Dinh,
L.D.Engstrom,
M.He,
J.Hoffman,
R.L.Hoffman,
P.S.Johnson,
R.S.Kania,
H.Lam,
J.L.Lam,
P.T.Le,
Q.Li,
L.Lingardo,
W.Liu,
M.W.Lu,
M.Mctigue,
C.L.Palmer,
P.F.Richardson,
N.W.Sach,
H.Shen,
T.Smeal,
G.L.Smith,
A.E.Stewart,
S.Timofeevski,
K.Tsaparikos,
H.Wang,
H.Zhu,
J.Zhu,
H.Y.Zou,
M.P.Edwards.
Design of Potent and Selective Inhibitors to Overcome Clinical Anaplastic Lymphoma Kinase Mutations Resistant to Crizotinib. J.Med.Chem. V. 57 1170 2014.
Page generated: Sat Dec 12 09:28:54 2020
ISSN: ISSN 0022-2623 PubMed: 24432909 DOI: 10.1021/JM401805H |
Last articlesZn in 8WB0Zn in 8WAX Zn in 8WAU Zn in 8WAZ Zn in 8WAY Zn in 8WAV Zn in 8WAW Zn in 8WAT Zn in 8W7M Zn in 8WD3 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |